10NEWS

Health

FDA Halts Regenxbio Gene Therapy Trial Again Amid Safety Issues

By Editor • August 24, 2026 • 1 min read

The FDA has paused Regenxbio's gene therapy trials for Hunter syndrome due to safety concerns after five patients showed spine masses.

By Editor • August 20, 2026 • 1 min read

The FDA has approved Ultragenyx's new gene therapy, marking a notable achievement in the biotech sector.

By Editor • August 19, 2026 • 1 min read

The deaths in Chinese clinical trials have sparked concerns about the oversight and safety of experimental medicine in the country.